Mucosal delivery of liposome-chitosan nanoparticle complexes

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmaceutical Sciences

Background:

• Parenteral administration faces challenges, driving interest in mucosal drug delivery.
• Colloidal carriers like nanoparticles and liposomes show promise but have limitations.
• Existing systems require improvement for specific mucosal administration routes.

Purpose of the Study:

• To develop a novel drug delivery system combining chitosan nanoparticles and liposomes.
• To overcome the limitations of individual nanoparticles and liposomes.
• To create a system for effective mucosal drug delivery with controlled release.

Main Methods:

• Two preparation strategies were employed: simple hydration and lyophilization followed by hydration.
• Lipid/chitosan nanoparticle complexes were formed.
• Encapsulated insulin release profiles and in vivo performance were evaluated.

Main Results:

• The developed systems demonstrated controlled release of encapsulated insulin.
• Release profiles were influenced by the lipid composition of the complexes.
• Satisfactory in vivo results confirmed the potential of these systems for mucosal delivery.

Conclusions:

• Lipid/chitosan nanoparticle complexes represent a promising drug delivery system.
• This hybrid approach effectively combines the advantages of chitosan nanoparticles and liposomes.
• The systems show significant potential for delivering therapeutic agents, like insulin, via mucosal routes.